The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
Dr. Oliver Sartor on the VISION Trial and Improving Care for Patients With mCRPC
Guest host Dr. Neeraj Agarwal, editor-in-chief of ASCO Daily News and director of the genitourinary cancers program at the University of Utah Huntsman Cancer Institute, interviews Dr. Oliver Sartor, medical director of the Tulane Cancer Center in New Orleans, on the practice-changing VISION trial and its impact on the current treatment paradigm for mCRPC.
Tackling the Increasing Incidence of Early-Onset Colorectal Cancer
Dr. Mohamed Salem, gastrointestinal medical oncologist at the Levine Cancer Institute at Atrium Health in North Carolina, tells guest host Dr. John Sweetenham, associate director of clinical affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, about the disturbing rise of early-onset colorectal cancer, the impact of socioeconomic disparities on patient outcomes and potential interventions to improve detection.
Key Interventions and Patient Perspectives From #ASCOQLTY21
Dr. Gabrielle Rocque, chair of the 2021 ASCO Quality Care Symposium, breast oncologist and health services researcher at the University of Alabama at Birmingham, and symposium chair-elect, Dr. Stephanie Wheeler, professor in the Department of Health Policy and Management at the University of North Carolina at Chapel Hill, discuss key interventions in quality care and compelling patient perspectives presented at #ASCOQLTY21.
Strategies to Improve Cancer Care for LGBTQI Patients and Survivors
Dr. Scout and Dr. Charles Kamen discuss the findings of a key survey by the National LGBT Cancer Network of LGBTQI cancer survivors and strategies to improve cancer care for sexual and gender minority patients and survivors. Dr. Scout is the executive director of the National LGBT Cancer Network. Dr. Kamen is a clinical psychologist at the University of Rochester Wilmot Cancer Center, and assistant professor in the Department of Surgery at the University of Rochester Medical Center.
Dr. Steve Pergam on COVID-19 Vaccine Booster Shots
Dr. Steve Pergam, associate professor of the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center and the Infection Prevention Director at Seattle Cancer Care Alliance, discusses new guidance from the National Comprehensive Cancer Network’s COVID-19 Vaccination Advisory Committee, regarding a third dose of the Pfizer-BioNTech or the Moderna COVID-19 vaccines for patients with cancer.
Dr. Derek Raghavan Has a Remedy to Mitigate Financial Toxicity in Cancer Treatment
Dr. Derek Raghavan, President of the Levine Cancer Institute in North Carolina discusses how the creation of a Financial Toxicity Tumor Board has substantially eased the financial burden on patients at his institution. He tells guest host, Dr. John Sweetenham, of UT Southwestern Howard C. Simmons Comprehensive Cancer Center, how this scalable approach to address financial toxicity has also educated physicians about reimbursement insurance and other issues impacting patients.